Supplementary Materials and Methods
Generation of cellular models to study DIS3L2 and DIS3L substrates.
The multistep cloning procedure described below was used to generate vectors for coexpression of recoded C-terminal FLAG-tagged DIS3L2 [wild type (WT) variant or its catalytic mutant counterpart (mut)] and sh-miRNAs directed against endogenous DIS3L2 mRNA (Supplementary Figure S12) .
We used the BLOCK-iT™ RNAi Designer tool from Invitrogen (with "miR RNAi" option) (http://rnaidesigner.invitrogen.com/rnaiexpress) to search for 3 miRNA sequences that should specifically and efficiently target endogenous DIS3L2 mRNA. We chose candidate sequences starting at nt positions 1473, 1583 and 1647 of the DIS3L2 ORF. Based on the general principles of BLOCK-iT™ Pol II miR RNAi Expression Vector Kits from Invitrogen (http://www.invitrogen.com/site/us/en/home/Products-and-Services/Applications/rnai/Vectorbased-RNAi/Pol-II-miR-RNAi-Vectors.html), we then designed a synthetic DNA fragment that encompassed a combination of the miRNA sequences listed above. This fragment encoded three tandemly-positioned shRNAs that corresponded to the pre-designed miRNAsso-called sh-miRs-where sense and antisense miRNA sequences were separated by a loop element that could form a hairpin (Supplementary Figure S13a) . Each of the sh-miR sequences was flanked at both termini with motifs to ensure correct miRNA processing from the artificial pre-miRNA precursor that followed a natural miRNA biogenesis pathway in human cells. In addition, polyadenylation signals derived from the gene encoding the herpes simplex virus thymidylate kinase (HSV-TK-PA) were placed at the 3'-end of this synthetic cassette to allow for correct termination of transcription in human cells. The cassette contained EcoRI/SalI and ClaI/HindIII restriction site combinations at the 5'-and 3'-ends, respectively, which were used in subsequent cloning steps. The cassette was synthesized by the BlueHeronBio company (http://blueheronbio.com) and inserted between the EcoRI and HindIII sites of the pUCAmpMinusMCS vector. Next, a eGFP sequence that allowed monitoring of the expression of the artificial pre-miRNA was amplified by PCR using an eGFPFor-eGFPRev primer pair (see Supplementary Table S2 for sequences) and pEGFP-N1 plasmid (Clontech) as a template and inserted into the EcoRI and SalI sites of the provided "[pUCAmpMinusMCS] tri-miR-L2" plasmid, to yield the "[pUCAmpMinusMCS'] eGFP-trimiR-L2" transitory construct (Supplementary Figure S12c) . Additionally, a site recognized by the XmaJI restriction endonuclease was introduced into the eGFPFor oligonucleotide upstream of the 5'-end of the eGFP ORF, which was used at a later cloning stage.
To use the BI-16 vector (1), we designed a cloning strategy to replace the existing hRLUC ORF with a DIS3L2 version that is insensitive to the action of microRNAs. Because in later stages of the cloning procedure the ApaI enzyme was used, we mutagenized the ApaI site present in the DIS3L2 ORF using mutD3L2F and mutD3L2R primers. Successful mutagenesis resulted in the temporary plasmids "p-ApaI-L2_WT" and "p-ApaI-L2_mut" that were confirmed by ApaI digestion and sequencing with DIS3L2_2, DIS3L2_3, DIS3L2_4, and DIS3L2_5 primers. After mutagenesis, inserts encompassing open reading frames coding for WT and mut variants of DIS3L2 were amplified with the DIS3L2F and DIS3L2R primer pair using "p-ApaI-L2_WT" and "p-ApaI-L2_mut" constructs as respective templates (the forward primer also introduced a MluI restriction site and a Kozak sequence at the 5' -end; the reverse primer carried a sequence encoding a FLAG-tag, STOP codon and restriction site (ApaI) at the 3' end). Next, the inserts were cloned into the MluI and ApaI sites of the vector to replace the hRLUC ORF in the MH1 E. coli strain (Supplementary Figure S12a To this end, we had the recoded fragment of DIS3L2 ORF synthesized (see Supplementary Figure S14a for nucleotide sequence alignment of original and recoded DIS3L2 ORF fragment). Recoding allowed the introduction of synonymous mutations into all possible codons (at those positions where the degenerative nature of the genetic code could be used and codon usage frequency taken into account) within the fragment containing sites recognized by miRNA, so that the sequence would diverge as much as possible from the original. We recoded a 600 nt-long fragment (nt 1261-1860 of the open reading frame) around the sh-miR target sites. This fragment covered all three sites that could be targeted by miRNAs yet was located outside the region where the catalytic mutation (D391N; change GAT to AAT at position 1171 of the ORF) is introduced. Our goal was to replace the endogenous DIS3L2 sequence with a recoded sequence using an overlap PCR method based on that described by Bryksin and Matsumura (2) . To this end, we ordered a recoded fragment surrounded by 75 nt flanking regions that were fully complementary to the initial sequence and terminated at both ends with sites recognized by the SchI restriction enzyme, which cleaves DNA at some distance from its site and yields blunt ends following cleavage. The ordered fragment was provided by BlueHeronBio as an insert that could be cloned into pUCAmpMinusMCS and then excised from the provided plasmid (propagated in the MH1 strain) with SchI. The resulting fragment was used as a "megaprimer" in overlap PCR to produce WT and mut recoded versions of DIS3L2 (250x molar excess of primer to plasmid We also used model cell lines for DIS3, EXOSC10 and DIS3L exosome catalytic subunits that were analogous to those described for DIS3L2. Some lines were previously established in our laboratory [DIS3 and EXOSC10 (3)], while the DIS3L lines were created for this study. Their generation is described below.
The cloning procedure to generate vectors that co-express recoded C-terminal FLAGtagged DIS3L [wild type (WT) variant or its catalytic mutant counterpart (mut)] and shmiRNAs directed against endogenous DIS3L mRNA was identical to that for DIS3L2, with the following exceptions:
1. Candidate sequences constituting miRNA targets started at nt positions 2414, 2621 and 2746 of the DIS3L ORF.
2. The BI-16 vector hRLUC ORF was replaced with miRNA-insensitive DIS3L. Because in the later stages of the cloning procedure the ClaI enzyme was used, we first removed the existing ClaI site in the DIS3L ORF by mutagenesis with the mutDISLF and mutDISLR primers. Successful mutagenesis resulted in the temporary plasmids "p-ClaI-L_WT" and "p-ClaI-L_mut" and was confirmed by ClaI digestion and sequencing (primers: E11fw, E13fw, E15rv, E5fw, E5rw, E8fw). After mutagenesis, inserts encompassing ORFs coding for WT and mut variants of DIS3L were amplified with the DIS3LF and DIS3LR primer pair using "p-ClaI-L_WT" and "p-ClaI-L_mut" constructs as respective templates. Inserts were cloned into the BI-16 vector as described for the DIS3L2 protein. This cellular model proved to be functional, because endogenous DIS3L transcript expression was reduced by 80% and we observed production of all relevant system components (data not shown).
Preparation of pcDNA5/FRT/TO plasmids for TUT4 and TUT7 overexpression
Parental pcDNA5/FRT/TO plasmids (ThermoFisher Scientific) were digested with FD BamHI and FD EcoRV (ThermoFisher Scientific). A cassette with 2 TEV protease cleavage site sequences was incorporated through two rounds of PCR using primer pairs p0_for1+p0_rev1, p0_for2+p0_rev2 (Supplementary Table S2 ) to amplify the entire plasmid sequence and add overhangs. The product of PCR2 was ligated using the SLIC approach (4) to generate plasmid p0. The final sequence of the incorporated cassette was:
This cassette contained the TEV sites (underlined) and AgeI and NheI restriction sites that are marked in bold and bold+italics, respectively.
To generate plasmids for N' tagging with eGFP, p0 was digested with AflII and BamHI (both within the parental pcDNA5/FRT/TO sequence) and the eGFP sequence was amplified by PCR using the pEGFP-C1 plasmid as a template and the primer pair p2_for+p2_rev comprising extensions for SLIC. The resulting DNAs were joined by SLIC to create the p2 plasmid.
The CDS of TUT4 (NCBI accession number NM_001009881) or TUT7
(NM_001185059) were amplified by standard PCR using the primer pairs ZCCHC11_F_FRTT+, ZCCHC11_R_FRTT_stop and
ZCCHC6_F_FRTT+ZCCHC6_R_FRTT_stop. The PCR products were cloned into an AgeIand NheI-cleaved p2 plasmid prepared as described above using the SLIC approach to generate pZW_GZ11 (TUT4) and pZW_GZ6 (TUT7).
Plasmids pZW_GZ11cm and pZW_GZ6cm for overexpression of catalyticallyinactive TUT mutants TUT4 D1011A and TUT7 D1060A were generated by a standard sitedirected mutagenesis protocol (5) using pZW_GZ11 and pZW_GZ6, respectively, as templates. 
Immunofluorescence and microscopy analysis

Flow cytometry analysis of eGFP expression
Stable inducible human Flp-In T-REx 293 cell lines were plated at a density of 3 × 10 5 cells
per well in a 6-well plate, and cultured for 24 hours in medium with or without doxycycline.
The cells were then detached from the plate by scraping in cell culture medium, centrifuged at 500 g for 3 min, washed with PBS, centrifuged again and resuspended in 0.5 ml PBS. eGFP signals were measured using a FACScalibur instrument (BD Biosciences) and the data were analysed using Cyflogic software (CyFlo Ltd.). 6) rabbit polyclonal α-DIS3L2 (1:1500, the same as (6)).
Western blotting
On the next day, the membranes were washed four times with TBST and incubated with horseradish peroxidase-conjugated goat anti-rabbit or anti-mouse secondary antibodies for 3 hours (Calbiochem, 401393 or 401215, 1:3000 for 1-2, 1:20000 for 3-4, 1:40000 for 5 and 1:10000 for 6).
Blots were washed four times for 10 min with TBST20 and developed with the ECL system (Amersham Biosciences) according to the manufacturer's protocol. Digital images were obtained with a CCD camera (Alpha Innotech) or blots were exposed to CL-Exposure films (ThermoFisher Scientific) and developed in an AGFA Curix CP-1000 apparatus.
Small RNA-Seq (detailed protocol)
The first steps of the small RNA-Seq protocol were identical to those of the standard RNASeq protocol (DNase treatment and ribodepletion of 10 μg total RNA). We then treated 
Flow cytometry analysis of cell cycle
Stable inducible human HEK293 cell lines were cultured in 100 mm dishes and treated with doxycycline (100 ng/ml) for 3 days. To analyse cell cycle, staining with propidium iodide (PI) was performed using a previously described procedure (7) with slight modifications. These modifications included: 1) changed centrifugation parameters to 4 min at 500 g; 2) changed RNase A concentration to 100 μg/ml; 3) changed staining time and temperature to 45 min at 37°C. Cells were read on an Attune NxT acoustic focusing cytometer (ThermoFisher) and fractions were calculated using dedicated software.
Primer Extension Analysis
Primer Extension Analysis was performed as previously described (8) . Sequencing ladders for regions under analysis were prepared from plasmids with a cloned genomic DNA fragment encompassing the vtRNA1-1 and Y4 genes (see Supplementary Table S2 for oligonucleotides used for sequencing and primer extension).
Cell fractionation
Stable inducible human HEK293 cell lines were cultured in 100 mm dishes and treated with doxycycline (100 ng/ml) for 3 days. After induction, cells were fractionated to obtain RNAs from different cellular compartments. The previously described procedure (9) was slightly modified as described below.
Cells were centrifuged at 500 g at 4°C for 5 min, resuspended in 380 μl ice-cold HLB supplemented with 100 U RiboLock RNase Inhibitor, incubated for 8 min on ice, vortexed briefly and centrifuged again at 500 g at 4°C for 3 min. The resulting supernatant contained cytoplasmic RNAs and the pellet corresponded to the nuclear fraction.
The supernatant was transferred to a new tube, 1 ml RPS was added and samples were stored at -20°C for at least 1 hour. Samples were then vortexed for 30 s and centrifuged at 18,000 g at 4°C for 15 min. The pellet was washed with ice-cold, 70% ethanol and centrifuged again at 18,000 g at 4°C for 5 min and partially air-dried before 1 ml TRI Reagent was added. In the meantime, the nuclear fraction was washed gently 3x with 1 ml ice-cold HLB and centrifuged at 500 g at 4°C for 2 min. Afterwards, 1 ml TRI Reagent was added.
Before standard RNA isolation, 10 μl 0.5 M EDTA was added to the samples in TRI Reagent and the pellets were heated to 65°C with vortexing until they dissolved.
4sU labelling
Stable inducible human HEK Flp-In T-REx cell lines producing WT/mut versions of DIS3L2 were cultured in 100 mm dishes and treated with doxycycline (100 ng/ml) for 3 days. Then, a previously described procedure (10) was carried out with minor modification as described below.
On the last day of induction, 4sU (Sigma) was added to the cell culture medium to a final concentration of 250 μM. Cells were incubated with 4sU for the indicated time periods, up to 120 min. The labelling reaction was terminated by the addition of TRI Reagent. RNA was then isolated as described previously, including non-treated controls. RNA (100 μg) was biotinylated by the addition of 100 μl 10x biotinylation buffer (100 mM Tris-HCl, pH 7.4, Table S2 ). The same oligonucleotides were used to generate sequencing ladders with DNA templates encompassing cloned genomic DNA fragments with vtRNA1-1 and Y4 genes. Both primer extension products and sequencing ladders were subjected to 6% denaturing PAGE and analysed by phosphorimaging. Reference sequences are shown next to the sequencing results. Supplementary Figure S7 . Localization of AluYa5 transcripts in different cellular compartments. Cell fractionation and northern blot were used for analysis. Lanes are marked 'tot' for total RNA, 'nuc' for nuclear RNA and 'cyt' for cytoplasmic RNA. RNB indicates the DIS3 mutant of exonucleolytic activity, while PIN+RNB denotes double endo-and exonucleolytic mutations in DIS3. Cell fractionation was monitored by assessing the presence of transcripts prevailing in a given cellular compartment -i.e., SNORD13 (nucleus) and RN7SL1 (cytoplasm).
Supplementary Figure S8. FTL_short possibly does not function in iron metabolism. (a)
After induction with doxycycline, WT and mut cells were treated for 24 hours with substances that alter environmental iron levels: FAC (ferric ammonium citrate) and DFO (deferoxamine). The amounts of FTL_short transcript were then analysed by northern blot. 5S rRNA was used as an internal control. Figure S13 . Cassettes with sequences encoding three sh-miRs silencing endogenous DIS3L2/DIS3L2 genes together with flanking sites. (a) Cassette for production of sh-miRs silencing DIS3L2 expression. Red, blue, green and violet letters denote EcoRI, SalI, ClaI and HindIII restriction sites, respectively, which were used during the cloning procedure; gray and black background represent 5' and 3' miR flanking regions, respectively; red background indicates 21 nt antisense target sequences (mature miRNA sequences); magenta background represents nucleotides 1-8 and 11-21 of the respective sense target sequences; green background indicates a 19 nt sequence derived from endogenous murine miR-155, and the underlined 13 nt segment can form a loop within the sh-miRNA structure; yellow background represents HSV-TK polyadenylation signal. (b) Same as a, but sh-miRs to silence DIS3L are shown.
(a)
DIS3L2
----------CTGCAAGCCACTCGCTGACGGCAACTTCAAAGTGGGAGTTCACATTGCTG 50 DIS3L2rec GAGTCATATACTGCAAGCCACTCGCTGACGGCAACTTCAAAGTGGGAGTTCACATTGCTG 60 ************************************************** DIS3L2  ACGTGAGTTACTTTGTTCCGGAGGGATCTGATCTGGATAAAGTGGCTGCCGAGAGGGCTA 110  DIS3L2rec ACGTGAGTTACTTTGTTCCGGAGGGAAGCGACCTCGACAAGGTCGCCGCTGAAAGAGCCA 120 ************************** ** ** ** ** ** ** ** ** ** ** *
C K P L A D G N F K V G V H I A
D V S Y F V P E G S D L D K V A A E R A
DIS3L2
CAAGCGTCTACTTGGTTCAAAAGGTGGTCCCCATGCTTCCCAGGCTGCTGTGTGAGGAGC 170 DIS3L2rec CCTCCGTGTATCTGGTGCAGAAAGTCGTGCCTATGCTGCCTAGACTTCTCTGCGAAGAAC 180 * *** ** **** ** ** ** ** ** ***** ** ** ** ** ** ** **
TCTGTTCCCTGAATCCTATGAGCGATAAACTCACATTTAGCGTCATTTGGACCCTCACCC 240 * ** *** ** ** *** *** ** ** ** ** ** ** ***** ** ** *
L C S L N P M S D K L T F S V I W T L T
DIS3L2
CAGAGGGCAAGATCCTTGATGAATGGTTTGGCCGGACCATCATCCGCTCCTGCACCAAAC 290 DIS3L2rec CCGAAGGAAAAATTCTGGACGAGTGGTTCGGAAGAACAATTATTAGGAGCTGTACAAAGC 300 * ** ** ** ** ** ** ** ***** ** * ** ** ** * *** ** ** * miR1473  DIS3L2  TTAGCTACGAGCATGCACAGAGCATGATTGAAAGCCCAACTGAGAAAATCCCTGCGAAAG 350  DIS3L2rec TGTCATATGAACACGCTCAATCAATGATCGAGAGCCCCACAGAAAAGATTCCAGCCAAGG 360 * ** ** ** ** ** ***** ** ***** ** ** ** ** ** ** ** * miR1583  DIS3L2  AGCTGCCCCCCATTTCCCCAGAGCATAGCAGCGAGGAGGTACACCAGGCCGTCTTGAATC 410  DIS3L2rec AACTCCCACCAATCAGCCCCGAACACTCATCAGAAGAAGTCCATCAAGCTGTGCTCAACC 420 * ** ** ** ** *** ** ** ** ** ** ** ** ** ** * ** *
P E G K I L D E W F G R T I I R S C T K
L S Y E H A Q S M I E S P T E K I P A K
E L P P I S P E H S S E E V H Q A V L N
DIS3L2
TCCACGGAATTGCCAAGCAGTTACGCCAGCAGCGCTTTGTGGACGGCGCACTTCGTTTGG 470 DIS3L2rec TGCATGGCATCGCTAAACAACTGAGGCAACAAAGGTTCGTCGATGGAGCTCTGAGGCTCG 480 * ** ** ** ** ** ** * * ** ** * ** ** ** ** ** ** * * *
ACCAACTGAAACTGGCCTTTACCCTCGATCATGAAACTGGCCTGCCCCAGGGCTGCCACA 540 * ** ** ** ** ** ** ** ** ** ** ** ** ** **** ** ** ** ** *
D Q L K L A F T L D H E T G L P Q G C H
DIS3L2 TCTATGAGTACCGCGAGAGCAACAAGCTCGTGGAGGAGTTCATGCTCTTGGCCAACATGG 590 DIS3L2rec
TTTACGAATATAGGGAATCCAATAAACTGGTCGAAGAATTTATGCTGCTGGCTAATATGG 600 * ** ** ** * ** *** ** ** ** ** ** ** ***** **** ** ****
I Y E Y R E S N K L V E E F M L L A N M
DIS3L2
CAGTGGCCCACAAGATCCACCGCGCCTTCCCCGAGCAGGCCCTGCTGCGCCGGCACCCCC 650 DIS3L2rec CCGTCGCTCATAAAATTCATAGAGCTTTTCCTGAACAAGCTCTCCTCAGAAGACATCCAC 660 * ** ** ** ** ** ** * ** ** ** ** ** ** ** ** * * ** ** *
A V A H K I H R A F P E Q A L L R R H P
DIS3L2 CGCCCCAAACAAGGATGCTCAGTGACCTGGTGGAATTCTGCGACCAGATGGGGCTGCCCG 710 DIS3L2rec
CCCCACAGACCAGAATGCTGTCCGATCTGGTGGAATTCTGCGACCAGATGGGGCTGCCCG 720 * ** ** ** ** ***** ** **********************************
TGGACTTCAGCTCCGCAGGAGCCCTCAATAAAAGCCTGACCTATATGACTC 771 *****************************************
GAGTCATATACGGTCCAATAAAACACTGGCTGATTCTCTGGATAATGCGAACGACCCCCA 60 **************************************************
R S N K T L A D S L D N A N D P
DIS3L CGATCCCATTGTGAACAGGCTACTGCGCTCCATGGCCACGCAGGCCATGTCGAATGCTCT 110 DIS3Lrec
CGATCCCATTGTGAACAGGCTACTGAGGAGCATGGCTACCCAAGCTATGAGCAACGCCCT 120 ************************* * ****** ** ** ** *** ** ** **
H D P I V N R L L R S M A T Q A M S N A
DIS3L
GTACTTCTCCACCGGATCCTGTGCGGAGGAGGAGTTCCATCATTACGGTCTTGCATTAGA 170 DIS3Lrec CTATTTTAGCACAGGCAGCTGCGCCGAAGAAGAATTTCACCACTATGGCCTGGCCCTGGA 180 ** ** *** ** *** ** ** ** ** ** ** ** ** ** ** ** * **
L Y F S T G S C A E E E F H H Y G L A L
miR2414
DIS3L
TAAATATACCCACTTTACTTCTCCAATAAGAAGATATTCAGATATTGTAGTACACCGCTT 230 DIS3Lrec
CAAGTACACACATTTCACCAGCCCCATCAGGCGGTACAGCGACATCGTCGTCCATAGGCT 240 ** ** ** ** ** ** ** ** ** * ** ** ** ** ** ** * *
D K Y T H F T S P I R R Y S D I V V H R
DIS3L
GTTAATGGCAGCCATTTCAAAAGATAAGAAAATGGAAATTAAGGGAAATCTGTTCAGCAA 290 DIS3Lrec
CCTGATGGCCGCAATCAGCAAGGACAAAAAGATGGAGATCAAAGGCAACCTCTTTTCTAA 300 * ***** ** ** ** ** ** ** ***** ** ** ** ** ** ** **
L L M A A I S K D K K M E I K G N L F S
DIS3L
CAAAGATCTTGAGGAATTATGCAGACATATCAACAACAGAAACCAAGCAGCACAGCATTC 350 DIS3Lrec TAAGGACCTGGAAGAGCTGTGTCGGCACATTAATAATCGGAATCAGGCCGCCCAACACAG 360 ** ** ** ** ** * ** * ** ** ** ** * ** ** ** ** ** **
N K D L E E L C R H I N N R N Q A A Q H
DIS3L
TCAGAAGCAGTCTACTGAGCTCTTCCAGTGCATGTACTTCAAAGACAAAGACCCTGCCAC 410 DIS3Lrec CCAAAAACAAAGCACAGAACTGTTTCAATGTATGTATTTTAAGGATAAGGATCCAGCAAC 420 ** ** ** ** ** ** ** ** ** ***** ** ** ** ** ** ** ** **
S Q K Q S T E L F Q C M Y F K D K D P A
miR2621
DIS3L
CGAGGAGCGTTGCATATCTGACGGAGTTATTTATTCAATTAGAACAAATGGTGTGCTTCT 470 DIS3Lrec
AGAAGAAAGGTGTATCAGCGATGGCGTGATCTACAGCATCCGGACCAACGGGGTCCTGCT 480 ** ** * ** ** ** ** ** ** ** ** * ** ** ** ** ** **
T E E R C I S D G V I Y S I R T N G V L
DIS3L
ATTTATACCAAGGTTTGGGATTAAAGGTGCTGCTTATCTAAAAAATAAAGATGGTTTAGT 530 DIS3Lrec
CTTCATCCCTCGCTTCGGCATCAAGGGAGCAGCATACCTCAAGAACAAGGACGGACTGGT 540 ** ** ** * ** ** ** ** ** ** ** ** ** ** ** ** ** ** * **
CATCTCATGTGGCCCAGATAGCTGTTCTGAATGGAAACCAGGATCCCTTCAACGATTTCA 590 DIS3Lrec GATTAGCTGCGGACCTGACAGTTGCAGCGAGTGGAAGCCTGGCAGCCTGCAGAGGTTCCA 600 ** ** ** ** ** ** ** ** ***** ** ** *** ** * ** **
V I S C G P D S C S E W K P G S L Q R F
DIS3L
AAACAAAATTACCTCTACTACAACAGATGGGGAATCTGTTACGTTCCATTTGTTTGACCA 650 DIS3Lrec GAATAAGATCACAAGCACCACCACCGACGGCGAGAGCGTGACCTTTCACCTGTTCGATCA 660 ** ** ** ** ** ** ** ** ** ** ** ** ** ** **** ** **
Q N K I T S T T T D G E S V T F H L F D
DIS3L
TGTAACCGTAAGAATATCCATACAGGCCTCACGTTGCCATTCTGATACAATCAGACTTGA 710 DIS3Lrec CGTGACAGTGAGGATCAGCATCCAAGCTTCCAGGTGTCACAGCGACACAATCAGACTTGA 720 ** ** ** ** ** *** ** ** ** * ** ** ** **************
H V T V R I S I Q A S R C H S D T I R L
DIS3L
AATAATTAGTAACAAACCATACAAGATACCAAATACAGAACTTATTCATCAGAGTTCCCC 770 DIS3Lrec AATAATTAGTAACAAACCATACAAGATACCAAATACAGAACTTATTCATCAGAGTTCCCC 780 ************************************************************ Supplementary Tables   1) Supplementary Table S1 RACE-Seq results presenting the amount of vtRNA1-2 and Y4 RNA transcripts ending in the indicated number of uridines. Grey background denotes genomic uridines. Supplementary Note
E I I S N K P Y K I P N T E L I H Q S S
The enhancement of DIS3L2-mediated vtRNA degradation by uridine addition was also shown for synthetic RNA substrates with different U tail lengths.
We in vitro transcribed either vtRNA1-2 with 4 uridines at the 3'-end (reflecting native unmodified vtRNA1-2 species) or its variants with an additional 2, 4 or 6 uridines at the 3'
termini (reflecting postranscriptionally uridylated species). After 5'-end labeling, we used those RNAs as substrates for our in vitro DIS3L2-mediated degradation assays. These analyses revealed enhanced degradation rates for extra-uridylated vtRNA1-2 substrates compared to their wild-type counterparts that lack an additional 3' U-tail (Supplementary Figure S6a,b) . Essentially, the presence of additional 3' terminal uridines decreased the halflife of full-length substrates from 18 min (wild-type=4Us), to 9 min (wild-type+2Us) and ~4 min (wild-type+4Us/6Us). The presence of 4 additional uridines at the 3'-end of vtRNA1-2 resulted in the fastest degradation kinetics and maximal degradation efficiency in our experimental conditions, with no further increase for substrates ending with an additional 6
Us. Taken together, we demonstrated that the presence of additional uridines at the 3' end of vtRNA1-2 significantly increased its degradation rate by DIS3L2 in vitro.
